Effect of Food on the Pharmacokinetics of Once-Daily Cyclobenzaprine Extended-Release 30 mgA Randomized, Open-Label, Crossover, Single-Centre Study

被引：0

作者：

Mona Darwish

Fang Xie

机构：

[1] Cephalon,Department of Clinical Pharmacology

[2] Inc.,Biometrics Department

[3] Cephalon,undefined

[4] Inc.,undefined

来源：

Clinical Drug Investigation | 2009年 / 29卷

关键词：

Oxybutynin; Food Effect; Tizanidine; Study Drug Administration; Aphthous Stomatitis;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Background and objective: Food can alter the bioavailability of the controlled-release formulations of many different drugs. This study assessed the effect of food on the pharmacokinetics of once-daily cyclobenzaprine extended-release (CER) in healthy adult subjects.

引用

页码：145 / 152

页数：7

共 50 条

[31] Pharmacokinetics of Prolonged-Release Once-Daily Formulations of Tacrolimus in De Novo Kidney Transplant Recipients: A Randomized, Parallel-Group, Open-Label, Multicenter Study
Kamar, Nassim
Cassuto, Elisabeth
Piotti, Giovanni
Govoni, Mirco
Ciurlia, Giorgia
Geraci, Silvia
Poli, Gianluigi
Nicolini, Gabriele
Mariat, Christophe
Essig, Marie
Malvezzi, Paolo
Le Meur, Yannick
Garrigue, Valerie
Del Bello, Arnaud
Rostaing, Lionel
ADVANCES IN THERAPY, 2019, 36 (02) : 462 - 477
[32] Effects of food on the bioavailability of gepirone from extended-release tablets in humans: Results of two open-label crossover studies
Fabre, LF
Timmer, CJ
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2003, 64 (08): : 580 - 598
[33] An open-label, crossover study of the pharmacokinetics of insoluble Drug Delivery®-MicroParticle fenofibrate in combination with atorvastatin, simvastatin, and extended-release niacin in healthy volunteers
Penn, R
Williams, RX
Guha-Ray, DK
Sawyers, WG
Braun, SL
Rains, KT
CLINICAL THERAPEUTICS, 2006, 28 (01) : 45 - 54
[34] The efficacy and safety of once-daily quetiapine extended release in patients with schizophrenia switched from other antipsychotics: an open-label study in Chinese population
Pei-Yin Pan
Meei-Shyuan Lee
Chin-Bin Yeh
BMC Psychiatry, 15
[35] Long-term, open-label, safety study of once-daily ropinirole extended/prolonged release in early and advanced Parkinson's disease
Makumi, Clare W.
Asgharian, Afsaneh
Ellis, Jeffrey
Shaikh, Soraya
Jimenez, Teri
VanMeter, Susan
INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2016, 126 (01) : 30 - 38
[36] Pharmacokinetics of diazepam administered intramuscularly by autoinjector versus rectal gel in healthy subjects: A phase I, randomized, open-label, single-dose, crossover, single-centre study
Lamson M.J.
Sitki-Green D.
Wannarka G.L.
Mesa M.
Andrews P.
Pellock J.
Clinical Drug Investigation, 2011, 31 (8) : 585 - 597
[37] Pharmacokinetics of Diazepam Administered Intramuscularly by Autoinjector versus Rectal Gel in Healthy Subjects A Phase I, Randomized, Open-Label, Single-Dose, Crossover, Single-Centre Study
Lamson, Michael J.
Sitki-Green, Diane
Wannarka, Gerald L.
Mesa, Michael
Andrews, Paul
Pellock, John
CLINICAL DRUG INVESTIGATION, 2011, 31 (08) : 585 - 597
[38] Pharmacokinetics and Antihypertensive Effects of Candesartan Cilexetil in Patients Undergoing HaemodialysisAn Open-Label, Single-Centre Study
Egbert G. Schulz
Shadfar Bahri
Volker Schettler
Aron-Frederik Popov
Matthias Hermann
Clinical Drug Investigation, 2009, 29 : 713 - 719
[39] Pharmacokinetics and Antihypertensive Effects of Candesartan Cilexetil in Patients Undergoing Haemodialysis An Open-Label, Single-Centre Study
Schulz, Egbert G.
Bahri, Shadfar
Schettler, Volker
Popov, Aron-Frederik
Hermann, Matthias
CLINICAL DRUG INVESTIGATION, 2009, 29 (11) : 713 - 719
[40] Pharmacokinetics of Extended-Release Dipyridamole following Administration through a Gastrostomy Tube An Open-Label, Case-Control, Two-Centre Study
Batista, Leonardo M.
Crandell, David
Lima, Fabricio O.
Greer, David M.
CLINICAL DRUG INVESTIGATION, 2010, 30 (07) : 483 - 488

← 1 2 3 4 5 →